Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders??? Equity (Unaudited)

v3.21.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 1,384 $ 75,890,295 $ 152,803 $ (37,473,580) $ 38,570,902
Balance (in Shares) at Dec. 31, 2019 13,846,925        
Stock based compensation:          
Common stock issued for cash $ 1 72,499 72,500
Common stock issued for cash (in Shares) 12,292        
Shares issued upon exchange of common stock equivalents $ 41 (41)
Shares issued upon exchange of common stock equivalents (in Shares) 410,170        
Beneficial conversion feature on convertible debt issued 329,300 329,300
Comprehensive income (loss):          
Net income (loss) (2,381,260) (2,381,260)
Other comprehensive income (loss) (1,844,205) (1,844,205)
Balance at Mar. 31, 2020 $ 1,426 76,292,053 (1,691,402) (39,854,840) 34,747,237
Balance (in Shares) at Mar. 31, 2020 14,269,387        
Stock based compensation:          
Shares issued upon exchange of common stock equivalents $ 6 (6)
Shares issued upon exchange of common stock equivalents (in Shares) 56,743        
Comprehensive income (loss):          
Net income (loss) 267,383 267,383
Other comprehensive income (loss) 867,244 867,244
Balance at Jun. 30, 2020 $ 1,432 76,292,047 (824,158) (39,587,457) 35,881,864
Balance (in Shares) at Jun. 30, 2020 14,326,130        
Stock based compensation:          
Shares issued upon exchange of common stock equivalents $ 17 (17)
Shares issued upon exchange of common stock equivalents (in Shares) 168,210        
Comprehensive income (loss):          
Net income (loss) (829,418) (829,418)
Other comprehensive income (loss) 414,335 414,335
Balance at Sep. 30, 2020 $ 1,449 76,292,030 (409,823) (40,416,875) 35,466,781
Balance (in Shares) at Sep. 30, 2020 14,494,340        
Balance at Dec. 31, 2020 $ 2,617 78,005,004 636,886 (48,357,638) 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Stock based compensation:          
Shares issued upon conversion of KBL debt $ 47 1,941,078 1,941,125
Shares issued upon conversion of KBL debt (in Shares) 467,123        
Shares issued upon conversion of 180 debt $ 16 432,367 432,383
Shares issued upon conversion of 180 debt (in Shares) 158,383        
Shares issued in connection with the financing, net of financing costs $ 256 10,730,814 10,731,070
Shares issued in connection with the financing, net of financing costs (in Shares) 2,564,000        
Offering costs allocated to warrant liabilities 604,118 604,118
Warrants issued in connection with private offering, reclassified to derivative liabilities (7,294,836) (7,294,836)
Shares issued upon exchange of common stock equivalents $ 96 (96)
Shares issued upon exchange of common stock equivalents (in Shares) 959,809        
Stock based compensation:          
Common stock $ 20 925,384 925,404
Common stock (in Shares) 197,790        
Options 1,092,399 1,092,399
Comprehensive income (loss):          
Net income (loss) (16,198,585) (16,198,585)
Other comprehensive income (loss) 189,348 189,348
Balance at Mar. 31, 2021 $ 3,052 86,436,232 826,234 (64,556,223) 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
Balance at Dec. 31, 2020 $ 2,617 78,005,004 636,886 (48,357,638) 30,286,869
Balance (in Shares) at Dec. 31, 2020 26,171,225        
Balance at Sep. 30, 2021 $ 3,399 106,153,999 701,904 (69,718,503) 37,140,799
Balance (in Shares) at Sep. 30, 2021 33,968,735        
Balance at Mar. 31, 2021 $ 3,052 86,436,232 826,234 (64,556,223) 22,709,295
Balance (in Shares) at Mar. 31, 2021 30,518,330        
Shares issued to settle accounts payable $ 23 1,973,227 1,973,250
Shares issued to settle accounts payable (in Shares) 225,000        
Impact of transfer agent reconciliation $ 28 (28)
Impact of transfer agent reconciliation (in Shares) 280,509        
Correction of an error (see Note 11) 363,523 363,523
Stock based compensation:          
Common stock $ 4 378,655 378,659
Common stock (in Shares) 37,515        
Options 344,095 344,095
Comprehensive income (loss):          
Net income (loss)   (23,459,136) (23,459,136)
Other comprehensive income (loss) 406,487 406,487
Balance at Jun. 30, 2021 $ 3,107 89,495,704 1,232,721 (88,015,359) 2,716,173
Balance (in Shares) at Jun. 30, 2021 31,061,354        
Shares issued in connection with the August 2021 Offering, net of financing costs $ 250 13,879,750 13,880,000
Shares issued in connection with the August 2021 Offering, net of financing costs (in Shares) 2,500,000        
Shares issued to settle convertible debt and derivative liabilities with Alpha Capital $ 15 1,060,485 1,060,500
Shares issued to settle convertible debt and derivative liabilities with Alpha Capital (in Shares) 150,000        
Shares issued in connection with the repayment of related party loans and convertible notes $ 15 851,097 851,112
Shares issued in connection with the repayment of related party loans and convertible notes (in Shares) 141,852        
Stock based compensation:          
Shares issued upon exchange of common stock equivalents $ 4 (4)
Shares issued upon exchange of common stock equivalents (in Shares) 44,240        
Stock based compensation:          
Common stock $ 8 431,988 431,996
Common stock (in Shares) 71,289        
Options 434,979 434,979
Comprehensive income (loss):          
Net income (loss) 18,296,856 18,296,856
Other comprehensive income (loss) (530,817) (530,817)
Balance at Sep. 30, 2021 $ 3,399 $ 106,153,999 $ 701,904 $ (69,718,503) $ 37,140,799
Balance (in Shares) at Sep. 30, 2021 33,968,735